BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31937562)

  • 21. Schimmelpenning-Feuerstein-Mims syndrome induced by HRAS Gly12Ser somatic mosaic mutation: Case report and literature review.
    Ono H; Yamaguchi R; Arai M; Togi S; Ura H; Niida Y; Shimizu A
    J Dermatol; 2023 Sep; 50(9):1213-1215. PubMed ID: 37170693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phacomatosis Pigmentokeratotica: A Mosaic RASopathy with Malignant Potential.
    Om A; Cathey SS; Gathings RM; Hudspeth M; Lee JA; Marzolf S; Wine Lee L
    Pediatr Dermatol; 2017 May; 34(3):352-355. PubMed ID: 28523882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BRAF, NRAS and HRAS mutations in spitzoid tumours and their possible pathogenetic significance.
    Da Forno PD; Pringle JH; Fletcher A; Bamford M; Su L; Potter L; Saldanha G
    Br J Dermatol; 2009 Aug; 161(2):364-72. PubMed ID: 19438459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebriform sebaceous nevus: a subtype of organoid nevus due to specific postzygotic FGFR2 mutations.
    Theiler M; Weibel L; Christen-Zaech S; Carmignac V; Sorlin A; Neuhaus K; Chevarin M; Thauvin-Robinet C; Philippe C; Faivre L; Vabres P; Kuentz P
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):2085-2090. PubMed ID: 33930231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low incidence of oncogenic EGFR, HRAS, and KRAS mutations in seborrheic keratosis.
    Georgieva IA; Mauerer A; Groesser L; Herschberger E; Aslanidis C; Dietmaier W; Landthaler M; Hafner C
    Am J Dermatopathol; 2014 Aug; 36(8):635-42. PubMed ID: 23739246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FGFR3 mutations in epidermal nevi and seborrheic keratoses: lessons from urothelium and skin.
    Hafner C; Hartmann A; Vogt T
    J Invest Dermatol; 2007 Jul; 127(7):1572-3. PubMed ID: 17568799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mosaic mutations in FGFR3 and FGFR2 are associated with naevoid acanthosis nigricans or RAVEN (round and velvety epidermal naevus).
    Larsabal M; Cogrel O; Caumont C; Jegou MH; Taïeb A; Morice-Picard F
    Br J Dermatol; 2019 Jan; 180(1):201-202. PubMed ID: 30117157
    [No Abstract]   [Full Text] [Related]  

  • 28. Somatic HRAS p.G12S mosaic mutation causes unilaterally distributed epidermal nevi, woolly hair and palmoplantar keratosis.
    Honda A; Umegaki-Arao N; Sasaki T; Nakabayashi K; Hata K; Matsubara Y; Tanikawa A; Amagai M; Kubo A
    J Dermatol; 2017 Jun; 44(6):e109-e110. PubMed ID: 28295558
    [No Abstract]   [Full Text] [Related]  

  • 29. Seborrheic keratosis arising on an epidermal nevus with HRAS p.G13R mutation.
    Kitamura S; Yanagi T; Imafuku K; Hata H; Fujii K; Nishihara H; Shimizu H
    Int J Dermatol; 2017 Sep; 56(9):e177-e180. PubMed ID: 28247919
    [No Abstract]   [Full Text] [Related]  

  • 30. Massively parallel sequencing analysis of benign melanocytic naevi.
    Lozada JR; Geyer FC; Selenica P; Brown D; Alemar B; Merghoub T; Berger MF; Busam KJ; Halpern AC; Weigelt B; Reis-Filho JS; Hollmann TJ
    Histopathology; 2019 Jul; 75(1):29-38. PubMed ID: 30791119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expanding mutational spectrum of HRAS by a patient with Schimmelpenning-Feuerstein-Mims syndrome.
    Luo Q; Zhang Q; Shen J; Guan W; Li M; Zhang J; Tan Z
    J Dermatol; 2021 Aug; 48(8):1273-1276. PubMed ID: 34109654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic analyses of a secondary poroma and trichoblastoma in a HRAS-mutated sebaceous nevus.
    Minowa T; Kamiya T; Hida T; Okura M; Kato J; Idogawa M; Tange S; Hirano T; Tokino T; Uhara H
    J Dermatol; 2021 Aug; 48(8):1268-1272. PubMed ID: 33908086
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidermal naevi associated with trichilemmal cysts and chromosomal mosaicism.
    Iglesias Zamora ME; Vázquez-Doval FJ
    Br J Dermatol; 1997 Nov; 137(5):821-4. PubMed ID: 9415250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidermal Nevi and Related Syndromes -- Part 1: Keratinocytic Nevi.
    Garcias-Ladaria J; Cuadrado Rosón M; Pascual-López M
    Actas Dermosifiliogr (Engl Ed); 2018 Oct; 109(8):677-686. PubMed ID: 29983155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maintenance of the bladder cancer precursor urothelial hyperplasia requires FOXA1 and persistent expression of oncogenic HRAS.
    Yee CH; Zheng Z; Shuman L; Yamashita H; Warrick JI; Wu XR; Raman JD; DeGraff DJ
    Sci Rep; 2019 Jan; 9(1):270. PubMed ID: 30670749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous Skeletal Hypophosphatemia Syndrome in Association with a Mosaic
    Park PG; Park E; Hyun HS; Kang HG; Ha IS; Cho TJ; Ko JM; Cheong HI
    Ann Clin Lab Sci; 2018 Sep; 48(5):665-669. PubMed ID: 30373874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Keratinocytic epidermal nevus with oral involvement and cleft palate.
    Menni S; Boccardi D; Gualandri L
    G Ital Dermatol Venereol; 2008 Oct; 143(5):347-9. PubMed ID: 18833076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clonality of basal cell carcinoma arising in an epidermal nevus. New insights provided by molecular analysis.
    Hafner C; Klein A; Landthaler M; Vogt T
    Dermatology; 2009; 218(3):278-81. PubMed ID: 19122450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple squamous cell carcinomas arising on an epidermal nevus harboring HRAS p.G13R mutation.
    Narahira A; Kitamura S; Maeda T; Nishihara H; Yanagi T
    J Dermatol; 2021 Feb; 48(2):e92-e93. PubMed ID: 33161608
    [No Abstract]   [Full Text] [Related]  

  • 40. Systematised naevus sebaceus resulting from post-zygotic mutation in HRAS.
    Hsu CK; Saito R; Nanda A; Rashidghamat E; Al-Ajmi H; Lee JY; Hide M; McGrath JA
    Australas J Dermatol; 2017 Feb; 58(1):58-60. PubMed ID: 26400620
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.